▶ 調査レポート

モメタゾンフロエートのグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Mometasone Furoate Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。モメタゾンフロエートのグローバル市場インサイト・予測(~2028年) / Global Mometasone Furoate Market Insights, Forecast to 2028 / QY2207E01664資料のイメージです。• レポートコード:QY2207E01664
• 出版社/出版日:QYResearch / 2022年7月
• レポート形態:英文、PDF、105ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のモメタゾンフロエートの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にモメタゾンフロエートの世界市場のxxx%を占める「モメタゾンフロエート無水物」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「クリーム」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のモメタゾンフロエートの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのモメタゾンフロエート市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのモメタゾンフロエート市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

モメタゾンフロエートのグローバル主要メーカーには、Cipla、Teva、Aarti Industries、Hovione、Symbiotec、Avik Pharmaceutical、Anuh Pharma、Xianju Pharmaceutical、New Hualian Pharmaceutical、Hangzhou Longshineなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

モメタゾンフロエート市場は、種類と用途によって区分されます。世界のモメタゾンフロエート市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
モメタゾンフロエート無水物、モメタゾンフロエート一水和物

【用途別セグメント】
クリーム、点鼻薬、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- モメタゾンフロエート製品概要
- 種類別市場(モメタゾンフロエート無水物、モメタゾンフロエート一水和物)
- 用途別市場(クリーム、点鼻薬、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のモメタゾンフロエート販売量予測2017-2028
- 世界のモメタゾンフロエート売上予測2017-2028
- モメタゾンフロエートの地域別販売量
- モメタゾンフロエートの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別モメタゾンフロエート販売量
- 主要メーカー別モメタゾンフロエート売上
- 主要メーカー別モメタゾンフロエート価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(モメタゾンフロエート無水物、モメタゾンフロエート一水和物)
- モメタゾンフロエートの種類別販売量
- モメタゾンフロエートの種類別売上
- モメタゾンフロエートの種類別価格
・用途別市場規模(クリーム、点鼻薬、その他)
- モメタゾンフロエートの用途別販売量
- モメタゾンフロエートの用途別売上
- モメタゾンフロエートの用途別価格
・北米市場
- 北米のモメタゾンフロエート市場規模(種類別、用途別)
- 主要国別のモメタゾンフロエート市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのモメタゾンフロエート市場規模(種類別、用途別)
- 主要国別のモメタゾンフロエート市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のモメタゾンフロエート市場規模(種類別、用途別)
- 主要国別のモメタゾンフロエート市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のモメタゾンフロエート市場規模(種類別、用途別)
- 主要国別のモメタゾンフロエート市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのモメタゾンフロエート市場規模(種類別、用途別)
- 主要国別のモメタゾンフロエート市場規模(トルコ、サウジアラビア)
・企業情報
Cipla、Teva、Aarti Industries、Hovione、Symbiotec、Avik Pharmaceutical、Anuh Pharma、Xianju Pharmaceutical、New Hualian Pharmaceutical、Hangzhou Longshine
・産業チェーン及び販売チャネル分析
- モメタゾンフロエートの産業チェーン分析
- モメタゾンフロエートの原材料
- モメタゾンフロエートの生産プロセス
- モメタゾンフロエートの販売及びマーケティング
- モメタゾンフロエートの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- モメタゾンフロエートの産業動向
- モメタゾンフロエートのマーケットドライバー
- モメタゾンフロエートの課題
- モメタゾンフロエートの阻害要因
・主な調査結果

Market Analysis and Insights: Global Mometasone Furoate Market
Due to the COVID-19 pandemic, the global Mometasone Furoate market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Mometasone Furoate Anhydrous accounting for % of the Mometasone Furoate global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cream segment is altered to an % CAGR throughout this forecast period.
China Mometasone Furoate market size is valued at US$ million in 2021, while the US and Europe Mometasone Furoate are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Mometasone Furoate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Mometasone Furoate include Cipla, Teva, Aarti Industries, Hovione, Symbiotec, Avik Pharmaceutical, Anuh Pharma, Xianju Pharmaceutical and New Hualian Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Mometasone Furoate capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Mometasone Furoate by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Mometasone Furoate Scope and Segment
Mometasone Furoate market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Mometasone Furoate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Mometasone Furoate Anhydrous
Mometasone Furoate Monohydrate
Segment by Application
Cream
Nasal Spray
Other
By Company
Cipla
Teva
Aarti Industries
Hovione
Symbiotec
Avik Pharmaceutical
Anuh Pharma
Xianju Pharmaceutical
New Hualian Pharmaceutical
Hangzhou Longshine
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Mometasone Furoate Product Introduction
1.2 Market by Type
1.2.1 Global Mometasone Furoate Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Mometasone Furoate Anhydrous
1.2.3 Mometasone Furoate Monohydrate
1.3 Market by Application
1.3.1 Global Mometasone Furoate Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Cream
1.3.3 Nasal Spray
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Mometasone Furoate Production
2.1 Global Mometasone Furoate Production Capacity (2017-2028)
2.2 Global Mometasone Furoate Production by Region: 2017 VS 2021 VS 2028
2.3 Global Mometasone Furoate Production by Region
2.3.1 Global Mometasone Furoate Historic Production by Region (2017-2022)
2.3.2 Global Mometasone Furoate Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Mometasone Furoate Sales in Volume & Value Estimates and Forecasts
3.1 Global Mometasone Furoate Sales Estimates and Forecasts 2017-2028
3.2 Global Mometasone Furoate Revenue Estimates and Forecasts 2017-2028
3.3 Global Mometasone Furoate Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Mometasone Furoate Sales by Region
3.4.1 Global Mometasone Furoate Sales by Region (2017-2022)
3.4.2 Global Sales Mometasone Furoate by Region (2023-2028)
3.5 Global Mometasone Furoate Revenue by Region
3.5.1 Global Mometasone Furoate Revenue by Region (2017-2022)
3.5.2 Global Mometasone Furoate Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Mometasone Furoate Production Capacity by Manufacturers
4.2 Global Mometasone Furoate Sales by Manufacturers
4.2.1 Global Mometasone Furoate Sales by Manufacturers (2017-2022)
4.2.2 Global Mometasone Furoate Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Mometasone Furoate in 2021
4.3 Global Mometasone Furoate Revenue by Manufacturers
4.3.1 Global Mometasone Furoate Revenue by Manufacturers (2017-2022)
4.3.2 Global Mometasone Furoate Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Mometasone Furoate Revenue in 2021
4.4 Global Mometasone Furoate Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Mometasone Furoate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Mometasone Furoate Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Mometasone Furoate Sales by Type
5.1.1 Global Mometasone Furoate Historical Sales by Type (2017-2022)
5.1.2 Global Mometasone Furoate Forecasted Sales by Type (2023-2028)
5.1.3 Global Mometasone Furoate Sales Market Share by Type (2017-2028)
5.2 Global Mometasone Furoate Revenue by Type
5.2.1 Global Mometasone Furoate Historical Revenue by Type (2017-2022)
5.2.2 Global Mometasone Furoate Forecasted Revenue by Type (2023-2028)
5.2.3 Global Mometasone Furoate Revenue Market Share by Type (2017-2028)
5.3 Global Mometasone Furoate Price by Type
5.3.1 Global Mometasone Furoate Price by Type (2017-2022)
5.3.2 Global Mometasone Furoate Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Mometasone Furoate Sales by Application
6.1.1 Global Mometasone Furoate Historical Sales by Application (2017-2022)
6.1.2 Global Mometasone Furoate Forecasted Sales by Application (2023-2028)
6.1.3 Global Mometasone Furoate Sales Market Share by Application (2017-2028)
6.2 Global Mometasone Furoate Revenue by Application
6.2.1 Global Mometasone Furoate Historical Revenue by Application (2017-2022)
6.2.2 Global Mometasone Furoate Forecasted Revenue by Application (2023-2028)
6.2.3 Global Mometasone Furoate Revenue Market Share by Application (2017-2028)
6.3 Global Mometasone Furoate Price by Application
6.3.1 Global Mometasone Furoate Price by Application (2017-2022)
6.3.2 Global Mometasone Furoate Price Forecast by Application (2023-2028)
7 North America
7.1 North America Mometasone Furoate Market Size by Type
7.1.1 North America Mometasone Furoate Sales by Type (2017-2028)
7.1.2 North America Mometasone Furoate Revenue by Type (2017-2028)
7.2 North America Mometasone Furoate Market Size by Application
7.2.1 North America Mometasone Furoate Sales by Application (2017-2028)
7.2.2 North America Mometasone Furoate Revenue by Application (2017-2028)
7.3 North America Mometasone Furoate Sales by Country
7.3.1 North America Mometasone Furoate Sales by Country (2017-2028)
7.3.2 North America Mometasone Furoate Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Mometasone Furoate Market Size by Type
8.1.1 Europe Mometasone Furoate Sales by Type (2017-2028)
8.1.2 Europe Mometasone Furoate Revenue by Type (2017-2028)
8.2 Europe Mometasone Furoate Market Size by Application
8.2.1 Europe Mometasone Furoate Sales by Application (2017-2028)
8.2.2 Europe Mometasone Furoate Revenue by Application (2017-2028)
8.3 Europe Mometasone Furoate Sales by Country
8.3.1 Europe Mometasone Furoate Sales by Country (2017-2028)
8.3.2 Europe Mometasone Furoate Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Mometasone Furoate Market Size by Type
9.1.1 Asia Pacific Mometasone Furoate Sales by Type (2017-2028)
9.1.2 Asia Pacific Mometasone Furoate Revenue by Type (2017-2028)
9.2 Asia Pacific Mometasone Furoate Market Size by Application
9.2.1 Asia Pacific Mometasone Furoate Sales by Application (2017-2028)
9.2.2 Asia Pacific Mometasone Furoate Revenue by Application (2017-2028)
9.3 Asia Pacific Mometasone Furoate Sales by Region
9.3.1 Asia Pacific Mometasone Furoate Sales by Region (2017-2028)
9.3.2 Asia Pacific Mometasone Furoate Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Mometasone Furoate Market Size by Type
10.1.1 Latin America Mometasone Furoate Sales by Type (2017-2028)
10.1.2 Latin America Mometasone Furoate Revenue by Type (2017-2028)
10.2 Latin America Mometasone Furoate Market Size by Application
10.2.1 Latin America Mometasone Furoate Sales by Application (2017-2028)
10.2.2 Latin America Mometasone Furoate Revenue by Application (2017-2028)
10.3 Latin America Mometasone Furoate Sales by Country
10.3.1 Latin America Mometasone Furoate Sales by Country (2017-2028)
10.3.2 Latin America Mometasone Furoate Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Mometasone Furoate Market Size by Type
11.1.1 Middle East and Africa Mometasone Furoate Sales by Type (2017-2028)
11.1.2 Middle East and Africa Mometasone Furoate Revenue by Type (2017-2028)
11.2 Middle East and Africa Mometasone Furoate Market Size by Application
11.2.1 Middle East and Africa Mometasone Furoate Sales by Application (2017-2028)
11.2.2 Middle East and Africa Mometasone Furoate Revenue by Application (2017-2028)
11.3 Middle East and Africa Mometasone Furoate Sales by Country
11.3.1 Middle East and Africa Mometasone Furoate Sales by Country (2017-2028)
11.3.2 Middle East and Africa Mometasone Furoate Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Cipla
12.1.1 Cipla Corporation Information
12.1.2 Cipla Overview
12.1.3 Cipla Mometasone Furoate Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Cipla Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Cipla Recent Developments
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Overview
12.2.3 Teva Mometasone Furoate Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Teva Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Teva Recent Developments
12.3 Aarti Industries
12.3.1 Aarti Industries Corporation Information
12.3.2 Aarti Industries Overview
12.3.3 Aarti Industries Mometasone Furoate Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Aarti Industries Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Aarti Industries Recent Developments
12.4 Hovione
12.4.1 Hovione Corporation Information
12.4.2 Hovione Overview
12.4.3 Hovione Mometasone Furoate Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Hovione Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Hovione Recent Developments
12.5 Symbiotec
12.5.1 Symbiotec Corporation Information
12.5.2 Symbiotec Overview
12.5.3 Symbiotec Mometasone Furoate Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Symbiotec Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Symbiotec Recent Developments
12.6 Avik Pharmaceutical
12.6.1 Avik Pharmaceutical Corporation Information
12.6.2 Avik Pharmaceutical Overview
12.6.3 Avik Pharmaceutical Mometasone Furoate Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Avik Pharmaceutical Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Avik Pharmaceutical Recent Developments
12.7 Anuh Pharma
12.7.1 Anuh Pharma Corporation Information
12.7.2 Anuh Pharma Overview
12.7.3 Anuh Pharma Mometasone Furoate Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Anuh Pharma Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Anuh Pharma Recent Developments
12.8 Xianju Pharmaceutical
12.8.1 Xianju Pharmaceutical Corporation Information
12.8.2 Xianju Pharmaceutical Overview
12.8.3 Xianju Pharmaceutical Mometasone Furoate Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Xianju Pharmaceutical Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Xianju Pharmaceutical Recent Developments
12.9 New Hualian Pharmaceutical
12.9.1 New Hualian Pharmaceutical Corporation Information
12.9.2 New Hualian Pharmaceutical Overview
12.9.3 New Hualian Pharmaceutical Mometasone Furoate Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 New Hualian Pharmaceutical Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 New Hualian Pharmaceutical Recent Developments
12.10 Hangzhou Longshine
12.10.1 Hangzhou Longshine Corporation Information
12.10.2 Hangzhou Longshine Overview
12.10.3 Hangzhou Longshine Mometasone Furoate Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Hangzhou Longshine Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Hangzhou Longshine Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Mometasone Furoate Industry Chain Analysis
13.2 Mometasone Furoate Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Mometasone Furoate Production Mode & Process
13.4 Mometasone Furoate Sales and Marketing
13.4.1 Mometasone Furoate Sales Channels
13.4.2 Mometasone Furoate Distributors
13.5 Mometasone Furoate Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Mometasone Furoate Industry Trends
14.2 Mometasone Furoate Market Drivers
14.3 Mometasone Furoate Market Challenges
14.4 Mometasone Furoate Market Restraints
15 Key Finding in The Global Mometasone Furoate Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Mometasone Furoate Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Mometasone Furoate Anhydrous
Table 3. Major Manufacturers of Mometasone Furoate Monohydrate
Table 4. Global Mometasone Furoate Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Mometasone Furoate Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Mometasone Furoate Production by Region (2017-2022) & (Tons)
Table 7. Global Mometasone Furoate Production Market Share by Region (2017-2022)
Table 8. Global Mometasone Furoate Production by Region (2023-2028) & (Tons)
Table 9. Global Mometasone Furoate Production Market Share by Region (2023-2028)
Table 10. Global Mometasone Furoate Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Mometasone Furoate Sales by Region (2017-2022) & (Tons)
Table 12. Global Mometasone Furoate Sales Market Share by Region (2017-2022)
Table 13. Global Mometasone Furoate Sales by Region (2023-2028) & (Tons)
Table 14. Global Mometasone Furoate Sales Market Share by Region (2023-2028)
Table 15. Global Mometasone Furoate Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Mometasone Furoate Revenue Market Share by Region (2017-2022)
Table 17. Global Mometasone Furoate Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Mometasone Furoate Revenue Market Share by Region (2023-2028)
Table 19. Global Mometasone Furoate Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Mometasone Furoate Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Mometasone Furoate Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Mometasone Furoate Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Mometasone Furoate Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Mometasone Furoate Revenue Share by Manufacturers (2017-2022)
Table 25. Mometasone Furoate Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Mometasone Furoate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Mometasone Furoate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mometasone Furoate as of 2021)
Table 28. Mometasone Furoate Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Mometasone Furoate Product Offered
Table 30. Date of Manufacturers Enter into Mometasone Furoate Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Mometasone Furoate Sales by Type (2017-2022) & (Tons)
Table 33. Global Mometasone Furoate Sales by Type (2023-2028) & (Tons)
Table 34. Global Mometasone Furoate Sales Share by Type (2017-2022)
Table 35. Global Mometasone Furoate Sales Share by Type (2023-2028)
Table 36. Global Mometasone Furoate Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Mometasone Furoate Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Mometasone Furoate Revenue Share by Type (2017-2022)
Table 39. Global Mometasone Furoate Revenue Share by Type (2023-2028)
Table 40. Mometasone Furoate Price by Type (2017-2022) & (US$/Ton)
Table 41. Global Mometasone Furoate Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global Mometasone Furoate Sales by Application (2017-2022) & (Tons)
Table 43. Global Mometasone Furoate Sales by Application (2023-2028) & (Tons)
Table 44. Global Mometasone Furoate Sales Share by Application (2017-2022)
Table 45. Global Mometasone Furoate Sales Share by Application (2023-2028)
Table 46. Global Mometasone Furoate Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Mometasone Furoate Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Mometasone Furoate Revenue Share by Application (2017-2022)
Table 49. Global Mometasone Furoate Revenue Share by Application (2023-2028)
Table 50. Mometasone Furoate Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Mometasone Furoate Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Mometasone Furoate Sales by Type (2017-2022) & (Tons)
Table 53. North America Mometasone Furoate Sales by Type (2023-2028) & (Tons)
Table 54. North America Mometasone Furoate Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Mometasone Furoate Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Mometasone Furoate Sales by Application (2017-2022) & (Tons)
Table 57. North America Mometasone Furoate Sales by Application (2023-2028) & (Tons)
Table 58. North America Mometasone Furoate Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Mometasone Furoate Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Mometasone Furoate Sales by Country (2017-2022) & (Tons)
Table 61. North America Mometasone Furoate Sales by Country (2023-2028) & (Tons)
Table 62. North America Mometasone Furoate Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Mometasone Furoate Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Mometasone Furoate Sales by Type (2017-2022) & (Tons)
Table 65. Europe Mometasone Furoate Sales by Type (2023-2028) & (Tons)
Table 66. Europe Mometasone Furoate Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Mometasone Furoate Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Mometasone Furoate Sales by Application (2017-2022) & (Tons)
Table 69. Europe Mometasone Furoate Sales by Application (2023-2028) & (Tons)
Table 70. Europe Mometasone Furoate Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Mometasone Furoate Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Mometasone Furoate Sales by Country (2017-2022) & (Tons)
Table 73. Europe Mometasone Furoate Sales by Country (2023-2028) & (Tons)
Table 74. Europe Mometasone Furoate Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Mometasone Furoate Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Mometasone Furoate Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Mometasone Furoate Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Mometasone Furoate Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Mometasone Furoate Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Mometasone Furoate Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Mometasone Furoate Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Mometasone Furoate Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Mometasone Furoate Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Mometasone Furoate Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Mometasone Furoate Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Mometasone Furoate Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Mometasone Furoate Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Mometasone Furoate Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Mometasone Furoate Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Mometasone Furoate Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Mometasone Furoate Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Mometasone Furoate Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Mometasone Furoate Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Mometasone Furoate Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Mometasone Furoate Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Mometasone Furoate Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Mometasone Furoate Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Mometasone Furoate Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Mometasone Furoate Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Mometasone Furoate Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Mometasone Furoate Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Mometasone Furoate Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Mometasone Furoate Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Mometasone Furoate Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Mometasone Furoate Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Mometasone Furoate Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Mometasone Furoate Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Mometasone Furoate Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Mometasone Furoate Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Mometasone Furoate Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Mometasone Furoate Revenue by Country (2023-2028) & (US$ Million)
Table 112. Cipla Corporation Information
Table 113. Cipla Description and Major Businesses
Table 114. Cipla Mometasone Furoate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. Cipla Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Cipla Recent Development
Table 117. Teva Corporation Information
Table 118. Teva Description and Major Businesses
Table 119. Teva Mometasone Furoate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Teva Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Teva Recent Development
Table 122. Aarti Industries Corporation Information
Table 123. Aarti Industries Description and Major Businesses
Table 124. Aarti Industries Mometasone Furoate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. Aarti Industries Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Aarti Industries Recent Development
Table 127. Hovione Corporation Information
Table 128. Hovione Description and Major Businesses
Table 129. Hovione Mometasone Furoate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. Hovione Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Hovione Recent Development
Table 132. Symbiotec Corporation Information
Table 133. Symbiotec Description and Major Businesses
Table 134. Symbiotec Mometasone Furoate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. Symbiotec Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Symbiotec Recent Development
Table 137. Avik Pharmaceutical Corporation Information
Table 138. Avik Pharmaceutical Description and Major Businesses
Table 139. Avik Pharmaceutical Mometasone Furoate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 140. Avik Pharmaceutical Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Avik Pharmaceutical Recent Development
Table 142. Anuh Pharma Corporation Information
Table 143. Anuh Pharma Description and Major Businesses
Table 144. Anuh Pharma Mometasone Furoate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 145. Anuh Pharma Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Anuh Pharma Recent Development
Table 147. Xianju Pharmaceutical Corporation Information
Table 148. Xianju Pharmaceutical Description and Major Businesses
Table 149. Xianju Pharmaceutical Mometasone Furoate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 150. Xianju Pharmaceutical Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Xianju Pharmaceutical Recent Development
Table 152. New Hualian Pharmaceutical Corporation Information
Table 153. New Hualian Pharmaceutical Description and Major Businesses
Table 154. New Hualian Pharmaceutical Mometasone Furoate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 155. New Hualian Pharmaceutical Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. New Hualian Pharmaceutical Recent Development
Table 157. Hangzhou Longshine Corporation Information
Table 158. Hangzhou Longshine Description and Major Businesses
Table 159. Hangzhou Longshine Mometasone Furoate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 160. Hangzhou Longshine Mometasone Furoate Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Hangzhou Longshine Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Mometasone Furoate Distributors List
Table 165. Mometasone Furoate Customers List
Table 166. Mometasone Furoate Market Trends
Table 167. Mometasone Furoate Market Drivers
Table 168. Mometasone Furoate Market Challenges
Table 169. Mometasone Furoate Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Mometasone Furoate Product Picture
Figure 2. Global Mometasone Furoate Market Share by Type in 2021 & 2028
Figure 3. Mometasone Furoate Anhydrous Product Picture
Figure 4. Mometasone Furoate Monohydrate Product Picture
Figure 5. Global Mometasone Furoate Market Share by Application in 2021 & 2028
Figure 6. Cream
Figure 7. Nasal Spray
Figure 8. Other
Figure 9. Mometasone Furoate Report Years Considered
Figure 10. Global Mometasone Furoate Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 11. Global Mometasone Furoate Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Mometasone Furoate Production Market Share by Region (2017-2022)
Figure 13. Global Mometasone Furoate Production Market Share by Region (2023-2028)
Figure 14. Mometasone Furoate Production Growth Rate in North America (2017-2028) & (Tons)
Figure 15. Mometasone Furoate Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 16. Mometasone Furoate Production Growth Rate in China (2017-2028) & (Tons)
Figure 17. Mometasone Furoate Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 18. Global Mometasone Furoate Sales 2017-2028 (Tons)
Figure 19. Global Mometasone Furoate Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 20. Global Mometasone Furoate Revenue 2017-2028 (US$ Million)
Figure 21. Global Mometasone Furoate Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 22. Global Mometasone Furoate Sales Market Share by Region (2017-2022)
Figure 23. Global Mometasone Furoate Sales Market Share by Region (2023-2028)
Figure 24. North America Mometasone Furoate Sales YoY (2017-2028) & (Tons)
Figure 25. North America Mometasone Furoate Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Europe Mometasone Furoate Sales YoY (2017-2028) & (Tons)
Figure 27. Europe Mometasone Furoate Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Mometasone Furoate Sales YoY (2017-2028) & (Tons)
Figure 29. Asia-Pacific Mometasone Furoate Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Latin America Mometasone Furoate Sales YoY (2017-2028) & (Tons)
Figure 31. Latin America Mometasone Furoate Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Middle East & Africa Mometasone Furoate Sales YoY (2017-2028) & (Tons)
Figure 33. Middle East & Africa Mometasone Furoate Revenue YoY (2017-2028) & (US$ Million)
Figure 34. The Mometasone Furoate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 35. The Top 5 and 10 Largest Manufacturers of Mometasone Furoate in the World: Market Share by Mometasone Furoate Revenue in 2021
Figure 36. Mometasone Furoate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 37. Global Mometasone Furoate Sales Market Share by Type (2017-2028)
Figure 38. Global Mometasone Furoate Revenue Market Share by Type (2017-2028)
Figure 39. Global Mometasone Furoate Sales Market Share by Application (2017-2028)
Figure 40. Global Mometasone Furoate Revenue Market Share by Application (2017-2028)
Figure 41. North America Mometasone Furoate Sales Market Share by Type (2017-2028)
Figure 42. North America Mometasone Furoate Revenue Market Share by Type (2017-2028)
Figure 43. North America Mometasone Furoate Sales Market Share by Application (2017-2028)
Figure 44. North America Mometasone Furoate Revenue Market Share by Application (2017-2028)
Figure 45. North America Mometasone Furoate Sales Share by Country (2017-2028)
Figure 46. North America Mometasone Furoate Revenue Share by Country (2017-2028)
Figure 47. United States Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 48. Canada Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 49. Europe Mometasone Furoate Sales Market Share by Type (2017-2028)
Figure 50. Europe Mometasone Furoate Revenue Market Share by Type (2017-2028)
Figure 51. Europe Mometasone Furoate Sales Market Share by Application (2017-2028)
Figure 52. Europe Mometasone Furoate Revenue Market Share by Application (2017-2028)
Figure 53. Europe Mometasone Furoate Sales Share by Country (2017-2028)
Figure 54. Europe Mometasone Furoate Revenue Share by Country (2017-2028)
Figure 55. Germany Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 56. France Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 57. U.K. Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 58. Italy Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 59. Russia Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 60. Asia Pacific Mometasone Furoate Sales Market Share by Type (2017-2028)
Figure 61. Asia Pacific Mometasone Furoate Revenue Market Share by Type (2017-2028)
Figure 62. Asia Pacific Mometasone Furoate Sales Market Share by Application (2017-2028)
Figure 63. Asia Pacific Mometasone Furoate Revenue Market Share by Application (2017-2028)
Figure 64. Asia Pacific Mometasone Furoate Sales Share by Region (2017-2028)
Figure 65. Asia Pacific Mometasone Furoate Revenue Share by Region (2017-2028)
Figure 66. China Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 67. Japan Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 68. South Korea Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 69. India Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 70. Australia Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 71. China Taiwan Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 72. Indonesia Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 73. Thailand Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 74. Malaysia Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 75. Latin America Mometasone Furoate Sales Market Share by Type (2017-2028)
Figure 76. Latin America Mometasone Furoate Revenue Market Share by Type (2017-2028)
Figure 77. Latin America Mometasone Furoate Sales Market Share by Application (2017-2028)
Figure 78. Latin America Mometasone Furoate Revenue Market Share by Application (2017-2028)
Figure 79. Latin America Mometasone Furoate Sales Share by Country (2017-2028)
Figure 80. Latin America Mometasone Furoate Revenue Share by Country (2017-2028)
Figure 81. Mexico Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 82. Brazil Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 83. Argentina Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 84. Middle East and Africa Mometasone Furoate Sales Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Mometasone Furoate Revenue Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Mometasone Furoate Sales Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Mometasone Furoate Revenue Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Mometasone Furoate Sales Share by Country (2017-2028)
Figure 89. Middle East and Africa Mometasone Furoate Revenue Share by Country (2017-2028)
Figure 90. Turkey Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 91. Saudi Arabia Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 92. UAE Mometasone Furoate Revenue (2017-2028) & (US$ Million)
Figure 93. Mometasone Furoate Value Chain
Figure 94. Mometasone Furoate Production Process
Figure 95. Channels of Distribution
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed